Press release
Aramid Fiber Market Key Market Players : Bayer Healthcare AG., AstraZenca, Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Boehringer Inghelheim Pharmaceutical, Inc., Altimed Pharma Inc., Altra laboratoriesLtd., Hoffmanm La Roche, Nanjing Pha
Antiplatelet Market
Antiplatelet drug is a pharmaceutical drug that reduces blood aggregation and inhibits thrombus formation. As, these drugs interfere the process of blood clot formation that accelerates the production of thrombin which stabilises the conversion of fibrogen to fibrin and dissolves the blood clots. Antiplatelet drugs are majorly used in the treatment and prevention of arterial thrombosis, which results into consequences of heart attack and relative cardiovascular disorders. Antiplatelet drugs are also called as Antithrombotic drugs.
Request for free sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/request-for-free-sample
Major indications treated with antiplatelet/antithrombotic drugs are all the cardiovascular diseases, acute ischaemic events, and atrial fibrillation. These indications are majorly caused due to damage of vessels, pregnancy, obesity, and genetics. Moreover, increasing smoking trend globally has also increased the prevalence these indications and has promoted the use of these drugs. According to CDC, smoking is one of the leading cause of death in the U.S.; every 1 out of 5 deaths in the U.S. are caused due to smoking.
Increasing production of generic antiplatelet drugs and significant increase for research and development globally to boost the antiplatelet market.
The global antiplatelet market is primarily driven by the factors like increasing use of antiplatelet/antithrombotic drugs for treating various disorders, rising ageing population, increasing thrombotic events globally, and increase in research and development for developing new drugs. Moreover, rising number incidences cardiovascular disorders of would also spur the market of these drugs. According to American Heart Association, heart stroke is no.1 leading cause of death in the U.S. i.e. someone in the U.S. have stroke every 40 seconds. In addition, the continuous increase in the investment for developing new drugs by the manufacturers by rising investment on research, and formation of executive products for the potential market would influence a positive growth for entire industry.
Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/
However, side effects like gastrointestinal disturbance and bleeding caused by all types of antiplatelet/antithrombotic drugs will hinder the market growth during the forecast period.
Global Antiplatelet Market Taxonomy
The global antiplatelet drug market is segmented on the basis of drugs, end users and geography.
• By Drug type
• Anticoagulant Drug
• Antiplatelet Drugs
• Thrombolytic Drugs
• By End Users
• Hospitals
• Emergency Service Centres
• Ambulatory Surgery Centres
• Others
Geographically, the global antiplatelet market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/global-antiplatelet-market/inquire-before-buying/
Rising elderly population to lead the global antiplatelet market in North America.
On the basis of geography, North America is expected to dominate the global antiplatelet drugs market over forecast period. The primary factors influencing growth of antiplatelet drug market in this region are increasing elderly population in North America, and high availability of patients suffering from cardiovascular diseases will positively influence the market of North Americas during the forecast period. While, Europe holds the second largest share for the market owning to the increasing geriatric population. The geriatric population in Europe is mainly attributed to the increased life expectancy, and improved medical infrastructure for treating various diseases.
However, Asia Pacific is expected to dominate the market in the forecast period. Increasing awareness for the use of antiplatelet drugs in treating various indication, and increasing geriatric population.
Key players in the global antiplatelet market are:
• Bayer Healthcare AG.
• AstraZenca
• Portola Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• Boehringer Inghelheim Pharmaceutical, Inc.
• Altimed Pharma Inc.
• Altra laboratoriesLtd.
• Hoffmanm La Roche
• Nanjing Pharmaceutical Factory
• Microbix Biosystems Inc.
• The Medicine Co.
• Emisphere Technologies
• Eli-Lily Co.
• Biovascular Inc.
• Daiichi Sankyo Co.
• Pfizer Inc.
About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aramid Fiber Market Key Market Players : Bayer Healthcare AG., AstraZenca, Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Boehringer Inghelheim Pharmaceutical, Inc., Altimed Pharma Inc., Altra laboratoriesLtd., Hoffmanm La Roche, Nanjing Pha here
News-ID: 1283584 • Views: …
More Releases from Polaris Market Research and Consulting.
Electric Power Distribution Automation Systems Market Analysis 2018| General Ele …
The global electric power distribution automation systems market generated $14.6 billion in 2017 and is anticipated to grow at a CAGR of 5.8% during the forecast period.
The electrical power distribution automation system consists of a series of intelligent processors, communication technologies and sensors that manage the distribution of electric power in a specific grid. These systems are mainly used in modern power grid framework and assist in automating the analysis…
Point-of-Sale (POS) Terminals Market 2018 Key Players VeriFone Systems, Oracle C …
According to a new study published by Polaris Market Research the worldwide Mobile POS Terminals market is anticipated to reach over USD 81.3 billion by 2026. In 2017, the hardware component dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue during the forecast period.
The rising number of cashless transactions and growing need for digital payments primarily…
Smart Agriculture Market 2018 Key Players are AG Leader Technology, AGCO Corpora …
The global smart agriculture market is anticipated to reach $20,635 million by 2026 according to the new research published by Polaris Market Research. In 2017, the hardware segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.
The global smart agriculture market is majorly driven by an increasing adoption of smart agriculture across the world owing…
Net-Zero Energy Buildings Market 2018 Top Key players are Siemens AG, General El …
The major players in the Net-Zero Energy Buildings Market Siemens AG, General Electric, Johnson Controls International plc, SunPower Corporation, Altura Associates, Inc., Sage Electrochromics, Inc., Daikin Industries Ltd., Schneider Electric, Kingspan Group plc, and Integrated Environmental Solutions (IES) Limited among others
According to a new research published by Polaris Market Research the Net-Zero Energy Buildings market is anticipated to reach over USD 96,008 million by 2026. In 2017, the commercial net-zero…
More Releases for Antiplatelet
The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology
Antiplatelet drugs are incorrectly referred to as blood thinners. They do not thin the blood, but interfere with the vital process by which the blood clots. Antiplatelet drugs usually reduce the aggregation of blood cells, reducing potentially harmful clots. Giving antiplatelet drugs to people at high risk of heart disease can help avoid the risk of stroke and heart attack .
Get Sample Copy of This Report @ …
Antiplatelet Drugs Market - Increasing incidence of cardiovascular diseases is e …
The report presents an in-depth assessment of the Antiplatelet Drugs Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of…
Dual Antiplatelet Therapy Market Value Insights, Analysis and Segments 2018 to 2 …
Dual antiplatelet therapy is defined as the use of aspirin and P2Y12 receptor inhibitor to prevent blood clotting, and through a double mechanism, it prevents thrombotic complications. The dual antiplatelet therapy is often prescribed for patients who had a cardiac attack, had coronary artery bypass graft surgery (CABG), or were treated with stents in coronary arteries. Growing prevalence of cardiovascular disease on the coattails of changing lifestyles habits is expected…
Dual Antiplatelet Therapy Market: Latest Report with Forecast 2018 to 2028
Platelets are small blood particles that clump together to form clots. Sometimes, these clots may lead to myocardial infarction or a sudden blockage in the coronary artery. Antiplatelets are a class of drugs that inhibit blood clot formation. Many heart attack and stroke patients are treated with two types of antiplatelet drugs to prevent blood clotting. This is known as dual antiplatelet therapy. Dual antiplatelet therapy is a combination therapy…
Antiplatelet Drugs Market Registering a Strong Growth by 2025
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided.
Antiplatelet agents are widely used…
Antiplatelet Drugs Market Significantly Expand During 2017 - 2025
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided.
Antiplatelet agents are widely used…
